IMAJ | volume 27
Journal 1, January 2025
pages: 54-56
1 Department of Cardiology, Galilee Medical Center, Nahariya, Israel
2 Genetics Institute Rambam Health Care Campus, Rappaport Faculty of Medicine, Technion–Israel Institute of Technology, Haifa, Israel
3 Azrieli Faculty of Medicine, Bar-Ilan University, Safed, Israel
Summary
Peripartum cardiomyopathy (PPCM) is an idiopathic cardiomyopathy presenting with heart failure (HF) secondary to left ventricular systolic dysfunction (defined as left ventricular ejection fraction [LVEF]) < 45% toward the end of pregnancy or in the months following delivery, where no other cause of HF is found. Complete understanding of the etiology is lacking, with higher incidence seen in advanced maternal age, multiple gestations, preeclampsia, and anemia [1]. Potential suggested causes include pathological immune response, hormonal abnormalities, stress cytokines, and nutritional deficiencies. Genetic predisposition was demonstrated in some PPCM, most commonly pathogenic loss-of-function truncating variants in Titin gene (TTN) [1]. Other causative genes reported are DMD, LAMP2, DSP, MYH6, SYNM, TPM1, and VCL [1].